Abstract
The tumor microenvironment restrains conventional T cell (Tconv) activation while facilitating the expansion of Tregs. Here we showed that Tregs’ advantage in the tumor milieu relies on supplemental energetic routes involving lipid metabolism. In murine models, tumor-infiltrating Tregs displayed intracellular lipid accumulation, which was attributable to an increased rate of fatty acid (FA) synthesis. Since the relative advantage in glucose uptake may fuel FA synthesis in intratumoral Tregs, we demonstrated that both glycolytic and oxidative metabolism contribute to Tregs’ expansion. We corroborated our data in human tumors showing that Tregs displayed a gene signature oriented toward glycolysis and lipid synthesis. Our data support a model in which signals from the tumor microenvironment induce a circuitry of glycolysis, FA synthesis, and oxidation that confers a preferential proliferative advantage to Tregs, whose targeting might represent a strategy for cancer treatment.
Funder
Associazione Italiana per la Ricerca sul Cancro
Ministero dell'Istruzione, dell'Università e della Ricerca
Fondazione Italiana Sclerosi Multipla
Istituto Pasteur-Fondazione Cenci Bolognetti
Institut Pasteur
Fondazione Roma
EC | Seventh Framework Programme
Fondazione Cariplo
Ministero della Salute
EC | FP7 | FP7 Ideas: European Research Council
Fondazione Umberto Veronesi
Publisher
Proceedings of the National Academy of Sciences
Cited by
241 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献